NVAX logo

Novavax (NVAX) Shareholders Equity

Annual Shareholders Equity

-$716.93 M
-$82.85 M-13.07%

31 December 2023

NVAX Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

-$526.44 M
-$94.73 M-21.94%

30 September 2024

NVAX Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVAX Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.1%+22.4%
3 y3 years-214.3%-214.1%
5 y5 years-326.9%-177.3%

NVAX Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-214.3%at low-214.1%+41.2%
5 y5 years-214.3%at low-150.7%+41.2%
alltimeall time-214.3%at low-150.7%+41.2%

Novavax Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
-$526.44 M(+21.9%)
June 2024
-
-$431.71 M(-50.2%)
Mar 2024
-
-$867.08 M(+20.9%)
Dec 2023
-$716.93 M(+13.1%)
-$716.93 M(+5.7%)
Sept 2023
-
-$678.35 M(-10.1%)
June 2023
-
-$754.52 M(-15.8%)
Mar 2023
-
-$895.58 M(+41.2%)
Dec 2022
-$634.08 M(+80.3%)
-$634.08 M(+12.0%)
Sept 2022
-
-$565.99 M(+35.7%)
June 2022
-
-$416.95 M(-738.3%)
Mar 2022
-
$65.32 M(-118.6%)
Dec 2021
-$351.67 M(-156.1%)
-$351.67 M(-176.2%)
Sept 2021
-
$461.34 M(-38.1%)
June 2021
-
$745.56 M(-28.3%)
Mar 2021
-
$1.04 B(+65.7%)
Dec 2020
$627.21 M(-437.2%)
$627.21 M(+489.3%)
Sept 2020
-
$106.44 M(-42.3%)
June 2020
-
$184.53 M(-869.8%)
Mar 2020
-
-$23.97 M(-87.1%)
Dec 2019
-$186.02 M(+10.8%)
-$186.02 M(-2.0%)
Sept 2019
-
-$189.84 M(+2.3%)
June 2019
-
-$185.49 M(+23.2%)
Mar 2019
-
-$150.58 M(-10.3%)
Dec 2018
-$167.94 M(+65.1%)
-$167.94 M(+32.6%)
Sept 2018
-
-$126.68 M(+44.4%)
June 2018
-
-$87.71 M(-11.7%)
Mar 2018
-
-$99.37 M(-2.3%)
Dec 2017
-$101.73 M(+1734.3%)
-$101.73 M(+37.2%)
Sept 2017
-
-$74.15 M(+25.5%)
June 2017
-
-$59.06 M(+103.0%)
Mar 2017
-
-$29.10 M(+424.7%)
Dec 2016
-$5.55 M(-101.9%)
-$5.55 M(-111.1%)
Sept 2016
-
$49.78 M(-54.8%)
June 2016
-
$110.12 M(-40.6%)
Mar 2016
-
$185.43 M(-36.6%)
Dec 2015
$292.67 M(+27.5%)
$292.67 M(-20.3%)
Sept 2015
-
$367.02 M(-5.3%)
June 2015
-
$387.60 M(-3.0%)
Mar 2015
-
$399.71 M(+74.1%)
Dec 2014
$229.62 M(+13.0%)
$229.62 M(-12.2%)
Sept 2014
-
$261.65 M(-7.1%)
June 2014
-
$281.73 M(+47.5%)
Mar 2014
-
$191.06 M(-6.0%)
Dec 2013
$203.23 M(+153.3%)
$203.23 M(-6.2%)
Sept 2013
-
$216.57 M(+212.9%)
June 2013
-
$69.23 M(-10.8%)
Mar 2013
-
$77.57 M(-3.3%)
Dec 2012
$80.24 M(+49.0%)
$80.24 M(+30.7%)
Sept 2012
-
$61.38 M(+0.5%)
June 2012
-
$61.08 M(+12.4%)
Mar 2012
-
$54.32 M(+0.9%)
Dec 2011
$53.85 M(-8.8%)
$53.85 M(-1.4%)
Sept 2011
-
$54.60 M(-3.0%)
June 2011
-
$56.27 M(+5.1%)
Mar 2011
-
$53.53 M(-9.3%)
Dec 2010
$59.05 M
$59.05 M(-11.9%)
Sept 2010
-
$66.99 M(+16.5%)
DateAnnualQuarterly
June 2010
-
$57.52 M(-8.9%)
Mar 2010
-
$63.14 M(-9.7%)
Dec 2009
$69.95 M(+53.8%)
$69.95 M(+4.4%)
Sept 2009
-
$67.02 M(+12.2%)
June 2009
-
$59.72 M(+58.0%)
Mar 2009
-
$37.79 M(-16.9%)
Dec 2008
$45.49 M(-27.9%)
$45.49 M(-19.0%)
Sept 2008
-
$56.13 M(+18.9%)
June 2008
-
$47.22 M(-15.4%)
Mar 2008
-
$55.80 M(-11.5%)
Dec 2007
$63.06 M(-32.9%)
$63.06 M(-12.3%)
Sept 2007
-
$71.88 M(-10.4%)
June 2007
-
$80.26 M(-7.9%)
Mar 2007
-
$87.11 M(-7.3%)
Dec 2006
$94.00 M(+89.3%)
$94.00 M(-5.2%)
Sept 2006
-
$99.14 M(-4.5%)
June 2006
-
$103.83 M(-4.8%)
Mar 2006
-
$109.11 M(+119.7%)
Dec 2005
$49.65 M(+49.2%)
$49.65 M(+149.5%)
Sept 2005
-
$19.90 M(+6.5%)
June 2005
-
$18.69 M(-23.4%)
Mar 2005
-
$24.39 M(-26.7%)
Dec 2004
$33.28 M(-7.4%)
$33.28 M(-23.6%)
Sept 2004
-
$43.54 M(+86.6%)
June 2004
-
$23.34 M(-24.1%)
Mar 2004
-
$30.75 M(-14.5%)
Dec 2003
$35.94 M(+345.2%)
$35.94 M(+180.1%)
Sept 2003
-
$12.83 M(-20.4%)
June 2003
-
$16.12 M(-18.1%)
Mar 2003
-
$19.70 M(+144.0%)
Dec 2002
$8.07 M(-70.6%)
$8.07 M(-38.1%)
Sept 2002
-
$13.04 M(-34.1%)
June 2002
-
$19.77 M(-14.1%)
Mar 2002
-
$23.03 M(-16.2%)
Dec 2001
$27.49 M(-13.6%)
$27.49 M(-8.3%)
Sept 2001
-
$30.00 M(+2.5%)
June 2001
-
$29.28 M(-3.3%)
Mar 2001
-
$30.27 M(-4.9%)
Dec 2000
$31.82 M(+1036.6%)
$31.82 M(+155.4%)
Sept 2000
-
$12.46 M(-16.5%)
June 2000
-
$14.92 M(-14.6%)
Mar 2000
-
$17.47 M(+524.0%)
Dec 1999
$2.80 M(-6.7%)
$2.80 M(-20.0%)
Sept 1999
-
$3.50 M(-32.7%)
June 1999
-
$5.20 M(+147.6%)
Mar 1999
-
$2.10 M(-30.0%)
Dec 1998
$3.00 M(-53.8%)
$3.00 M(-69.4%)
Sept 1998
-
$9.80 M(-9.3%)
June 1998
-
$10.80 M(-8.5%)
Mar 1998
-
$11.80 M(+81.5%)
Dec 1997
$6.50 M(+27.5%)
$6.50 M(-9.7%)
Sept 1997
-
$7.20 M(-11.1%)
June 1997
-
$8.10 M(-11.0%)
Mar 1997
-
$9.10 M(+78.4%)
Dec 1996
$5.10 M
$5.10 M(+4.1%)
Sept 1996
-
$4.90 M(-10.9%)
June 1996
-
$5.50 M(-12.7%)
Mar 1996
-
$6.30 M

FAQ

  • What is Novavax annual stockholders equity?
  • What is the all time high annual shareholders equity for Novavax?
  • What is Novavax annual shareholders equity year-on-year change?
  • What is Novavax quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Novavax?
  • What is Novavax quarterly shareholders equity year-on-year change?

What is Novavax annual stockholders equity?

The current annual shareholders equity of NVAX is -$716.93 M

What is the all time high annual shareholders equity for Novavax?

Novavax all-time high annual stockholders equity is $627.21 M

What is Novavax annual shareholders equity year-on-year change?

Over the past year, NVAX annual stockholders equity has changed by -$82.85 M (-13.07%)

What is Novavax quarterly stockholders equity?

The current quarterly shareholders equity of NVAX is -$526.44 M

What is the all time high quarterly shareholders equity for Novavax?

Novavax all-time high quarterly stockholders equity is $1.04 B

What is Novavax quarterly shareholders equity year-on-year change?

Over the past year, NVAX quarterly stockholders equity has changed by +$151.91 M (+22.39%)